fda approved glp-1 agonists Benefits and Risks of Receptor Outlined FDA-Approved Dosages and Indications for
Description
Future drugs may target three or more receptors simultaneously

In a response to questions about Pfizer ending the trial of its oral drug, a company spokesperson pointed Scientific American to the press release that announced that decision and said Pfizer is working on other early-stage oral drug candidates for weight loss, including one that works on a similar hormone to GLP-1 that is currently in phase 2 clinical trials

doi: 10.1016/j.regpep.2004.08.026

The findings from this ESM and pedometer data will be presented in a subsequent article

Nowhile berberine may offer mild benefits for blood sugar or metabolism, it does not work like GLP-1 medications and is not comparable in effectiveness
